Title: Direct Activation of Fission Yeast Adenylyl Cyclase by Heterotrimeric g protein Gpa2


Table II. Improvement in painful muscle cramps after Shakuyaku-kanzo-to treatment and eperisone hydrochloride  Therapeutic effect



tải về 361.3 Kb.
Chế độ xem pdf
trang6/9
Chuyển đổi dữ liệu01.11.2023
Kích361.3 Kb.
#55511
1   2   3   4   5   6   7   8   9
Shakuyaku-kanzo-to (Shao-Yao-Gan-Cao-Tang) as Treatment of Painful Muscle Cramps in Patients with Lumbar Spinal Stenosis and Its Minimum Effective Dose

Table II. Improvement in painful muscle cramps after Shakuyaku-kanzo-to treatment and eperisone hydrochloride 
Therapeutic effect
No.(%) of patients of 
Shakuyaku-kanzo-to 
No.(%) of patients of 
Eperisone hydrochloride 
Complete response 
8 (50.0) 
1 (7.14) 
Partial response 
6 (37.5) 
3 (21.43) 
Minor response 
1 (6.25) 
3 (21.43) 
No response 
1 (6.25) 
7 (50) 
Total 
16 (100) 
14 (100) 


PAINFUL MUSCLE CRAMPS TREATED BY SHAKUYAKU-KANZO-TO
E135 
Time required for the maximum therapeutic effect 
We investigated how many days were needed from the start of administration to achieve the maximum 
therapeutic effect. For 11 patients, fewer than 3 days were required; for 2 patients, 3-7 days; for 1 patient, 7-14 
days; and for 1 patient, more than 14 days (Figure 2). In more than half of the 16 patients, therefore, the 
maximum therapeutic effects occurred within less than 3 days. 
The chi-square test showed an association between therapeutic effect and time required for the maximum 
therapeutic effect (χ

= 33.01, P < 0.001). 
Figure 2. Time required for the maximum therapeutic effect

We classified 16 patients based on the days that were needed from the start of administration to achieve the 
maximum therapeutic effect. 
Minimum effective dose of Shakuyaku-kanzo-to 
We interviewed patients at 12 weeks after the treatment started. Symptoms were alleviated in 26 of 28 
patients, with dosages at that time as follows: 7.5 g/day for 5 patients, 5 g/day for 5 patients, 2.5 g/day for 8 
patients, 2.5 g as needed for 5 patients, and completed treatment for 3 patients.
We then calculated the patients’ response scores according to the frequency of muscle cramps. The scores of 
the group that had completed treatment were significantly lower than those of all other groups. No significant 
difference was observed among any other groups (Figure 3). 
Figure 3. Dosages and responses to painful muscle cramps 
Response scores were defined as a complete response: 3 points; partial response: 2 points; minor response: 1 
point; no response: 0 points; dropout: -1 point. The error bar indicates the SD. Differences in response scores 
were assessed by using one-way analysis of variance (ANOVA) with Tukey’s post-hoc test.
*P < 0.05; **P < 0.01. 


Y. TAKAO et al. 
E136 

tải về 361.3 Kb.

Chia sẻ với bạn bè của bạn:
1   2   3   4   5   6   7   8   9




Cơ sở dữ liệu được bảo vệ bởi bản quyền ©hocday.com 2024
được sử dụng cho việc quản lý

    Quê hương